NXbio Development AB is a Swedish AB based in Matfors, operating in the Manufacture of pharmaceutical preparations sector. Incorporated in 1995, the company has 2 employees and reported revenue of SEK 0 in its latest annual filing.
In its most recent annual report (2024), NXbio Development AB reported revenue of SEK 0. The figures on this page draw on 5 annual filings covering 2020 to 2024. The bottom line showed a net loss of SEK 11.0m.
At the end of 2024, equity financed 36.7% of the balance sheet, and current assets covered short-term debt 2,178.4 times.
Frequently asked questions
What is the Org number of NXbio Development AB?
NXbio Development AB is registered with Bolagsverket / SCB under Org 5565121794.
How many employees does NXbio Development AB have?
NXbio Development AB employs 2 people as of the latest annual report.
Who is the chairman of NXbio Development AB?
Maria Ingrid Rynell chairs the board of NXbio Development AB, in role since 2022.
Where is NXbio Development AB headquartered?
NXbio Development AB's registered address is Storjordenvägen 2.
